170 related articles for article (PubMed ID: 31293637)
1. Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.
Devi GR; Hough H; Barrett N; Cristofanilli M; Overmoyer B; Spector N; Ueno NT; Woodward W; Kirkpatrick J; Vincent B; Williams KP; Finley C; Duff B; Worthy V; McCall S; Hollister BA; Palmer G; Force J; Westbrook K; Fayanju O; Suneja G; Dent SF; Hwang ES; Patierno SR; Marcom PK
J Cancer; 2019; 10(15):3344-3351. PubMed ID: 31293637
[TBL] [Abstract][Full Text] [Related]
2. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory breast cancer (IBC) advocacy-Past, present and future!
Donahue J; Earls J; Fraser V; Mason G; Pirowski H; Stephens P
Int Rev Cell Mol Biol; 2024; 384():153-164. PubMed ID: 38637097
[TBL] [Abstract][Full Text] [Related]
4. Survivorship and Advocacy in Inflammatory Breast Cancer.
Alexander A; Arnold TL; Bishnoi S; Ballinger C; Shaitelman SF; Schaverien MV; Cohen L; Dev M; Ueno NT
J Cancer; 2018; 9(8):1430-1436. PubMed ID: 29721053
[TBL] [Abstract][Full Text] [Related]
5. Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States.
Scott L; Mobley LR; Il'yasova D
Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28398259
[TBL] [Abstract][Full Text] [Related]
6. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Dawood S; Merajver SD; Viens P; Vermeulen PB; Swain SM; Buchholz TA; Dirix LY; Levine PH; Lucci A; Krishnamurthy S; Robertson FM; Woodward WA; Yang WT; Ueno NT; Cristofanilli M
Ann Oncol; 2011 Mar; 22(3):515-523. PubMed ID: 20603440
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research.
Jagsi R; Mason G; Overmoyer BA; Woodward WA; Badve S; Schneider RJ; Lang JE; Alpaugh M; Williams KP; Vaught D; Smith A; Smith K; Miller KD;
Breast Cancer Res Treat; 2022 Apr; 192(2):235-243. PubMed ID: 34973083
[TBL] [Abstract][Full Text] [Related]
8. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10
Woodward WA; Cristofanilli M; Merajver SD; Van Laere S; Pusztai L; Bertucci F; Berditchevski F; Polyak K; Overmoyer B; Devi GR; Sterneck E; Schneider R; Debeb BG; Wang X; van Golen KL; El-Zein R; Rahal OM; Alexander A; Reuben JM; Krishnamurthy S; Lucci A; Ueno NT
J Cancer; 2017; 8(17):3607-3614. PubMed ID: 29667990
[TBL] [Abstract][Full Text] [Related]
9. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.
Ueno NT; Espinosa Fernandez JR; Cristofanilli M; Overmoyer B; Rea D; Berdichevski F; El-Shinawi M; Bellon J; Le-Petross HT; Lucci A; Babiera G; DeSnyder SM; Teshome M; Chang E; Lim B; Krishnamurthy S; Stauder MC; Parmar S; Mohamed MM; Alexander A; Valero V; Woodward WA
J Cancer; 2018; 9(8):1437-1447. PubMed ID: 29721054
[TBL] [Abstract][Full Text] [Related]
10. Building cross-border collaborations to increase diversity and accelerate rare disease drug development - meeting report from the inaugural IndoUSrare Annual Conference 2021.
Khera HK; Venugopal N; Karur RT; Mishra R; Kartha RV; Rajasimha HK
Ther Adv Rare Dis; 2022; 3():26330040221133124. PubMed ID: 37180411
[TBL] [Abstract][Full Text] [Related]
11. The patient advocate view.
Johnson GO; Kirschenbaum M; Mason G; Rush LR
Breast Dis; 2005-2006; 22():3-8. PubMed ID: 16735782
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
Sawaki M; Ito Y; Akiyama F; Tokudome N; Horii R; Mizunuma N; Takahashi S; Horikoshi N; Imai T; Nakao A; Kasumi F; Sakamoto G; Hatake K
Breast Cancer; 2006; 13(2):172-8. PubMed ID: 16755113
[TBL] [Abstract][Full Text] [Related]
13. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory breast cancer: patient advocate view.
Mason G; Johnson O
Semin Oncol; 2008 Feb; 35(1):87-91. PubMed ID: 18308150
[TBL] [Abstract][Full Text] [Related]
15. Critical Care Network in the State of Qatar.
Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
[TBL] [Abstract][Full Text] [Related]
16. Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.
Denu RA; Hampton JM; Currey A; Anderson RT; Cress RD; Fleming ST; Lipscomb J; Wu XC; Wilson JF; Trentham-Dietz A
J Cancer Epidemiol; 2017; 2017():7574946. PubMed ID: 28894467
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory breast carcinoma: a community hospital experience.
Brooks HL; Mandava N; Pizzi WF; Shah S
J Am Coll Surg; 1998 Jun; 186(6):622-9. PubMed ID: 9632147
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
[TBL] [Abstract][Full Text] [Related]
19. Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management.
Devi GR; Fish LJ; Bennion A; Sawin GE; Weaver SM; Reddy K; Saincher R; Tran AN
Prev Med Rep; 2023 Dec; 36():102519. PubMed ID: 38116289
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
Jacene HA; DiPiro PJ; Bellon J; Hu J; Cheng SC; Warren L; Schlosnagle E; Nakhlis F; Rosenbluth JM; Yeh E; Overmoyer B
Breast Cancer Res Treat; 2020 Jun; 181(2):383-390. PubMed ID: 32318957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
